Free Trial

Tate & Lyle (LON:TATE) Sets New 1-Year Low - What's Next?

Tate & Lyle logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Tate & Lyle hit a new 52-week low — shares traded as low as GBX 350.20 and last at GBX 351.60 on volume of 698,426.
  • Valuation and technicals point to weakness: market cap £1.55bn, P/E 62.79 and PEG 1.37, and the stock is trading below its 50-day (GBX 379.06) and 200-day (GBX 403.22) moving averages.
  • Business and balance-sheet snapshot — the company supplies ingredients across three segments (Food & Beverage Solutions, Sucralose, Primary Products) and reports a quick ratio of 1.77, current ratio of 2.19 and debt-to-equity of 83.31.
  • MarketBeat previews the top five stocks to own by May 1st.

Tate & Lyle plc (LON:TATE - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The company traded as low as GBX 350.20 and last traded at GBX 351.60, with a volume of 698426 shares changing hands. The stock had previously closed at GBX 351.20.

Tate & Lyle Price Performance

The company has a market cap of £1.55 billion, a price-to-earnings ratio of 62.79, a P/E/G ratio of 1.37 and a beta of 0.29. The company has a 50 day moving average price of GBX 379.06 and a 200-day moving average price of GBX 403.22. The company has a quick ratio of 1.77, a current ratio of 2.19 and a debt-to-equity ratio of 83.31.

Tate & Lyle Company Profile

(Get Free Report)

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; fibres; and stabilizers and functional systems.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tate & Lyle Right Now?

Before you consider Tate & Lyle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tate & Lyle wasn't on the list.

While Tate & Lyle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines